KYMRHealthcareMid-Cap
Kymera Therapeutics, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Kymera Therapeutics, Inc. (KYMR), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are KYMR insiders buying or selling?
Kymera Therapeutics, Inc. insiders reported 13 open-market buys ($286.1M) and 115 sells ($685.0M) across 128 Form 4 filings — a net selling position of $398.8M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 8, 2026)
Total Form 4 filings
128
SEC EDGAR
Insider filers
17
Insider buys (13)
$286.1M
Insider sells (115)
$685.0M
Insider sentiment
Net sellingNet insider flow of $398.8M in net selling.
Recent KYMR insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 8, 2026 | Nello Mainolfi | Chief Executive Officer | Sale | 50.0K | $119.00 | $6.0M |
| Jul 2, 2026 | Bruce N. Jacobs | Chief Financial Officer | Sale | 77.1K | $114.96 | $8.9M |
| Jul 2, 2026 | Noah Goodman | Chief Business Officer | Sale | 3.4K | $114.29 | $387.3K |
| Jul 2, 2026 | Nello Mainolfi | Chief Executive Officer | Sale | 80.0K | $115.29 | $9.2M |
| Jun 30, 2026 | Bruce Booth | Director | Sale | 31.3K | $109.48 | $3.4M |
| Jun 30, 2026 | Bruce Booth | Director | Sale | 513.2K | $110.01 | $56.5M |
| Jun 26, 2026 | Mark N Lampert | Director | Sale | 1.6M | $106.50 | $173.7M |
| Jun 26, 2026 | Bruce Booth | Director | Sale | 285.7K | $121.86 | $34.8M |
| Jun 26, 2026 | Bruce Booth | Director | Sale | 398.8K | $110.31 | $44.0M |
| Jun 25, 2026 | Noah Goodman | Chief Business Officer | Sale | 5.0K | $114.00 | $570.0K |
| Jun 23, 2026 | Bruce Booth | Director | Sale | 31.8K | $103.75 | $3.3M |
| Jun 23, 2026 | Bruce Booth | Director | Sale | 478.2K | $94.72 | $45.3M |
| Jun 22, 2026 | Noah Goodman | Chief Business Officer | Sale | 2.5K | $99.00 | $247.5K |
| May 27, 2026 | Jeremy G Chadwick | Chief Operating Officer | Sale | 17.2K | $79.92 | $1.4M |
| May 11, 2026 | Elena Ridloff | Director | Sale | 3.0K | $87.00 | $261.0K |
| Apr 29, 2026 | Nello Mainolfi | Chief Executive Officer | Sale | 30.0K | $81.18 | $2.4M |
| Apr 24, 2026 | Bruce Booth | Director | Sale | 6.0K | $89.96 | $539.8K |
| Apr 24, 2026 | Jeremy G Chadwick | Chief Operating Officer | Sale | 300 | $90.00 | $27.0K |
| Apr 16, 2026 | Noah Goodman | Chief Business Officer | Sale | 1.3K | $90.00 | $121.2K |
| Apr 16, 2026 | Jeremy G Chadwick | Chief Operating Officer | Sale | 6.6K | $90.00 | $589.6K |
| Apr 16, 2026 | Bruce Booth | Director | Sale | 9.5K | $90.01 | $854.5K |
| Apr 10, 2026 | Noah Goodman | Chief Business Officer | Sale | 10.3K | $87.47 | $897.8K |
| Apr 1, 2026 | Jeremy G Chadwick | Chief Operating Officer | Sale | 22.2K | $85.43 | $1.9M |
| Apr 1, 2026 | Elena Ridloff | Director | Sale | 12.0K | $85.39 | $1.0M |
| Mar 25, 2026 | Jeremy G Chadwick | Chief Operating Officer | Sale | 116.0K | $78.02 | $9.0M |
Showing the 25 most recent of 128 Form 4 filings for Kymera Therapeutics, Inc..
Most active KYMR insiders
- Nello Mainolfi21 filings
- Bruce Booth20 filings
- Jared Gollob14 filings
- Bruce N. Jacobs13 filings
- Mark N Lampert11 filings
Ask anything about KYMR insider activity
Use Trabud's AI agent to query Kymera Therapeutics, Inc.'s Form 4 history in plain English — "Show me KYMR CEO purchases this year" or compare it against any other ticker.
Open the AI agentKYMR insider trading FAQ
Are Kymera Therapeutics, Inc. insiders buying or selling?
Across 128 SEC Form 4 filings, Kymera Therapeutics, Inc. (KYMR) insiders reported 13 open-market purchases totaling $286.1M and 115 sales totaling $685.0M. That is a net selling position of $398.8M.
How many insiders trade KYMR stock?
17 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Kymera Therapeutics, Inc.. The most recent filing was accepted on Jul 8, 2026.
Where does Trabud get KYMR insider trading data?
All KYMR insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.